Zobrazeno 1 - 10
of 516
pro vyhledávání: '"Jérôme Alexandre"'
Autor:
Lucia Parlati, Mehdi Sakka, Aurelia Retbi, Samir Bouam, Lamia Hassani, Jean-François Meritet, Pierre Rufat, Dominique Bonnefont-Rousselot, Rui Batista, Benoit Terris, Agnès Bellanger, Dominique Thabut, Aurore Vozy, Jean-Philippe Spano, Romain Coriat, François Goldwasser, Selim Aractingi, Philippe Sogni, Stanislas Pol, Vincent Mallet, Jérôme Alexandre, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Sixtine De Percin, Nora Kramkimel, Olivier Huillard, Jeanne Chapron, Benedicte Deau-Fischer, Marie-Laure Brandely-Piat, Diane Damotte, Audrey Lupo, Marco Alifano, Marion Corouge, Clémence Hollande, Hélène Fontaine, Lorianne Lair Mehiri, Anaïs Vallet Pichard, Patrick Tilleul
Publikováno v:
JHEP Reports, Vol 5, Iss 12, Pp 100880- (2023)
Background & Aims: There is concern about the burden of liver injury in patients with cancer exposed to immune checkpoints inhibitors (ICIs). Methods: In a retrospective cohort study, we evaluated the likelihood of grade 3/4 liver injury, of grade 3/
Externí odkaz:
https://doaj.org/article/788878b251bf4c95a2f7143042e64143
Autor:
Karen Leroy, Clarisse Audigier Valette, Jérôme Alexandre, Lise Boussemart, Jean Chiesa, Clotilde Deldycke, Carlos Gomez-Rocca, Antoine Hollebecque, Jacqueline Lehmann-Che, Antoinette Lemoine, Sandrine Mansard, Jacques Medioni, Isabelle Monnet, Samia Mourah, Thomas Pierret, Dominique Spaëth, Alexandre Civet, Sandrine Galoin, Antoine Italiano
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0291495 (2023)
IntroductionConsidering the growing interest in matched cancer treatment, our aim was to evaluate the ability of a comprehensive genomic profiling (CGP) assay to propose at least one targeted therapy given an identified genomic alteration or signatur
Externí odkaz:
https://doaj.org/article/8bec3a2beb214f7a869dd1f1edcdeb6c
Autor:
Clara Vigneron, Julien Charpentier, Sandrine Valade, Jérôme Alexandre, Samy Chelabi, Lola-Jade Palmieri, Nathalie Franck, Valérie Laurence, Jean-Paul Mira, Matthieu Jamme, Frédéric Pène
Publikováno v:
Annals of Intensive Care, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Background Major therapeutic advances including immunotherapy and targeted therapies have been changing the face of oncology and resulted in improved prognosis as well as in new toxic complications. The aim of this study is to appraise the t
Externí odkaz:
https://doaj.org/article/a9a7c1acfb784abb83a1fa8b610b77ac
Autor:
François Gernier, Djihane Ahmed-Lecheheb, Patricia Pautier, Anne Floquet, Cédric Nadeau, Sophie Frank, Jérôme Alexandre, Frédéric Selle, Dominique Berton-Rigaud, Elsa Kalbacher, Hubert Orfeuvre, Alain Lortholary, Paule Augereau, Fabien Labombarda, Lionel Perrier, Jean-Michel Grellard, Idlir Licaj, Bénédicte Clarisse, Aude-Marie Savoye, Héloise Bourien, Thibaut De La Motte Rouge, Jean-Emmanuel Kurtz, Katia Kerdja, Anaïs Lelaidier, Amandine Charreton, Isabelle Ray-Coquard, Florence Joly
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Germ cell tumors and sex cord stromal tumors are rare cancers of the ovary. They mainly affect young women and are associated with a high survival rate. The standard treatment mainly involves conservative surgery combined with che
Externí odkaz:
https://doaj.org/article/884f84c2dbae400c9a68850b0e830310
Autor:
Lucie Allard, Jérôme Alexandre Denis, Gaëlle Godiris Petit, Gabrielle Deniziaut, Cécile Ghander, Elise Mathy, Erell Guillerm, Charlotte Lussey-Lepoutre, Laurence Leenhardt, Camille Buffet
Publikováno v:
European Thyroid Journal, Vol 11, Iss 2, Pp 1-2 (2023)
An 87-year-old woman was referred to our department for a 15 cm right-sided cervical tumor with bleeding and skin ulceration, developed on a 6 cm papillary thyroid carcinoma diagnosed two years earlier. Surprisingly, there were no other compressive s
Externí odkaz:
https://doaj.org/article/b51a0e4cea8645848e1b397808475dd2
Autor:
Yutaro Kaneko, Ryo Hatano, Naoto Hirota, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Fanny Valleix, Thomas Podoll, Yoshimi Umezawa, Seiichi Takao, Satoshi Iwata, Osamu Hosono, Tetsuo Taguchi, Taketo Yamada, Nam H. Dang, Kei Ohnuma, Eric Angevin, Chikao Morimoto
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)
Abstract Background The phase I trial of the humanized anti-CD26 monoclonal antibody YS110 for CD26-expressing tumors was conducted recently. The present study identifies a potential prognostic biomarker for CD26-targeted therapy based on the phase I
Externí odkaz:
https://doaj.org/article/869532e7d9924a45b065a8c40a83cd05
Autor:
Anaïs Prouteau, Jérôme Alexandre Denis, Pauline De Fornel, Edouard Cadieu, Thomas Derrien, Camille Kergal, Nadine Botherel, Ronan Ulvé, Mélanie Rault, Amira Bouzidi, Romain François, Laetitia Dorso, Alexandra Lespagnol, Patrick Devauchelle, Jérôme Abadie, Catherine André, Benoît Hédan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Circulating tumor DNA (ctDNA) has become an attractive biomarker in human oncology, and its use may be informative in canine cancer. Thus, we used droplet digital PCR or PCR for antigen receptor rearrangement, to explore tumor-specific point
Externí odkaz:
https://doaj.org/article/c87311cd4a064dffbfa0311c6446ab39
First referral to an integrated onco-palliative care program: a retrospective analysis of its timing
Autor:
Claire Barth, Isabelle Colombet, Vincent Montheil, Olivier Huillard, Pascaline Boudou-Rouquette, Camille Tlemsani, Jérôme Alexandre, François Goldwasser, Pascale Vinant
Publikováno v:
BMC Palliative Care, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background Palliative care (PC) referral is recommended early in the course of advanced cancer. This study aims to describe, in an integrated onco-palliative care program (IOPC), patient’s profile when first referred to this program, timin
Externí odkaz:
https://doaj.org/article/611ea8a61c2b4e118a65c53d1259a40a
Autor:
Pascaline Boudou-Rouquette, Jennifer Arrondeau, Claire Gervais, Jean-Philippe Durand, Elizabeth Fabre, Sixtine De Percin, Clémentine Vaquin Villeminey, Anne-Catherine Piketty, Nathalie Rassy, Guillaume Ulmann, Diane Damotte, Audrey Mansuet-Lupo, Frédérique Giraud, Marco Alifano, Marie Wislez, Jérôme Alexandre, Anne Jouinot, François Goldwasser
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103630- (2021)
Background: Immune checkpoint inhibitors (ICI) are dramatically active in a minority of non-small cell lung cancer (NSCLC) patients. We studied here the relationship between patients's metabolism and outcome under ICI. Methods: Metastatic NSCLC patie
Externí odkaz:
https://doaj.org/article/c752ad522f9e41baab6f8929446462cf
Autor:
Dominique Berton, Anne Floquet, Willy Lescaut, Gabriel Baron, Marie-Christine Kaminsky, Philippe Toussaint, Rémy Largillier, Aude-Marie Savoye, Jérôme Alexandre, Catherine Delbaldo, Emmanuelle Malaurie, Hugues Barletta, Claire Bosacki, Claire Garnier-Tixidre, Philippe Follana, Hortense Laharie-Mineur, Charles Briac Levache, Bruno Valenza, Agnès Dechartres, Delphine Mollon-Grange, Frédéric Selle
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Bevacizumab-containing therapy is considered a standard-of-care front-line option for stage IIIB–IV ovarian cancer based on results of randomized phase 3 trials. The multicenter non-interventional ENCOURAGE prospective cohort study as
Externí odkaz:
https://doaj.org/article/759e5d59f76b40d9ba13a0b2c9ebd372